Parkinson’s disease grafts benefit from well-timed growth factor

Nature, Published online: 26 May 2020; doi:10.1038/d41586-020-01486-3

Grafts of stem-cell-derived precursors of dopamine neurons could be used to treat Parkinson’s disease, but this approach has limitations. Injecting a growth factor three weeks after transplantation can overcome some of these limits.